Format
Sort by
Items per page

Send to

Choose Destination

Best matches for primary B-cell lymphoma of large B-cell:

Search results

Items: 1 to 20 of 7141

1.

[Clinical Analysis of 37 Patients with Primary Tonsil Diffuse Large B Cell Lymphoma].

Tian T, Wang L, Zhu HY, Liang JH, Wu W, Cao L, Fan L, Li JY, Xu W.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019 Apr;27(2):426-432. doi: 10.19746/j.cnki.issn.1009-2137.2019.02.019. Chinese.

PMID:
30998149
2.

Clinical features and outcomes of diffuse large B-cell lymphoma based on nodal or extranodal primary sites of origin: Analysis of 1,085 WHO classified cases in a single institution in China.

Shi Y, Han Y, Yang J, Liu P, He X, Zhang C, Zhou S, Zhou L, Qin Y, Song Y, Liu Y, Wang S, Jin J, Gui L, Sun Y.

Chin J Cancer Res. 2019 Feb;31(1):152-161. doi: 10.21147/j.issn.1000-9604.2019.01.10.

3.

X-Linked Lymphoproliferative Syndrome Presenting as Adult-Onset Multi-Infarct Dementia.

Blackburn PR, Lin WL, Miller DA, Lorenzo-Betancor O, Edwards ES, Zimmermann MT, Farrugia LP, Freeman WD, Soto AI, Walton RL, Klee EW, Atwal PS, Abraham RS, Billadeau DD, Ross OA, Dickson DW, Meschia JF.

J Neuropathol Exp Neurol. 2019 May 1;78(5):460-466. doi: 10.1093/jnen/nlz018.

PMID:
30990878
4.

Rare presentation of disseminated follicular lymphoma as an ill-defined reticular patch over the scalp and forehead.

Talebi-Liasi F, Sandhu S.

JAAD Case Rep. 2019 Apr 2;5(4):319-322. doi: 10.1016/j.jdcr.2019.02.022. eCollection 2019 Apr. No abstract available.

5.

Leg Type Primary Cutaneous Diffuse Large B-Cell Lymphoma.

D'Arena G, Galdo G, Lalinga V, Miraglia A, Pietrantuono G, Musto P, Vita G.

Indian J Hematol Blood Transfus. 2019 Apr;35(2):378-379. doi: 10.1007/s12288-018-1036-8. Epub 2018 Oct 29. No abstract available.

PMID:
30988585
6.

Clinicopathological spectrum of renal parenchymal involvement in B-cell lymphoproliferative disorders.

Javaugue V, Debiais-Delpech C, Nouvier M, Gand E, Chauvet S, Ecotiere L, Desport E, Goujon JM, Delwail V, Guidez S, Tomowiak C, Leleu X, Jaccard A, Rioux-Leclerc N, Vigneau C, Fermand JP, Touchard G, Thierry A, Bridoux F.

Kidney Int. 2019 Mar 15. pii: S0085-2538(19)30169-3. doi: 10.1016/j.kint.2019.01.027. [Epub ahead of print]

PMID:
30987838
7.

CD20-negative primary middle ear diffuse large B-cell lymphoma coexpressing MYC and BCL-2 secondary to acute lymphoblastic leukemia: A case report.

Ding C, Huang Y, Shi M, Nie B, Li Y, Wu K, Yang J, Zeng Y.

Medicine (Baltimore). 2019 Apr;98(15):e15204. doi: 10.1097/MD.0000000000015204.

8.

Chronic CD30-signaling in B cells results in lymphomagenesis by driving the expansion of plasmablasts and B1 cells.

Sperling SA, Fiedler P, Lechner M, Pollithy A, Ehrenberg S, Schiefer AI, Kenner L, Feuchtinger A, Kühn R, Swinerd G, Schmidt-Supprian M, Strobl LJ, Zimber-Strobl U.

Blood. 2019 Apr 8. pii: blood.2018880138. doi: 10.1182/blood.2018880138. [Epub ahead of print]

PMID:
30962205
9.

Epstein-Barr virus-positive pyothorax-associated lymphoma expresses CCL17 and CCL22 chemokines that attract CCR4-expressing regulatory T cells.

Higuchi T, Matsuo K, Hashida Y, Kitahata K, Ujihara T, Taniguchi A, Yoshie O, Nakayama T, Daibata M.

Cancer Lett. 2019 Apr 3;453:184-192. doi: 10.1016/j.canlet.2019.03.053. [Epub ahead of print]

PMID:
30953706
10.

Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.

Han Y, Yang J, Liu P, He X, Zhang C, Zhou S, Zhou L, Qin Y, Song Y, Sun Y, Shi Y.

Oncologist. 2019 Apr 5. pii: theoncologist.2018-0361. doi: 10.1634/theoncologist.2018-0361. [Epub ahead of print]

PMID:
30952824
11.

Primary Mediastinal Large B-Cell Lymphoma in a Child Presenting With Superior Mediastinal Syndrome and Chylous Pleural and Pericardial Effusion.

Trivedi M, Chandar R, Nair M, Jacob PM, Thankamony P.

J Pediatr Hematol Oncol. 2019 Apr 3. doi: 10.1097/MPH.0000000000001472. [Epub ahead of print]

PMID:
30951026
12.

Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial.

Davies A, Cummin TE, Barrans S, Maishman T, Mamot C, Novak U, Caddy J, Stanton L, Kazmi-Stokes S, McMillan A, Fields P, Pocock C, Collins GP, Stephens R, Cucco F, Clipson A, Sha C, Tooze R, Care MA, Griffiths G, Du MQ, Westhead DR, Burton C, Johnson PWM.

Lancet Oncol. 2019 Apr 1. pii: S1470-2045(18)30935-5. doi: 10.1016/S1470-2045(18)30935-5. [Epub ahead of print]

13.

Clinical characteristics and prognosis associated with multiple primary malignant tumors in non-Hodgkin lymphoma patients.

Jiang Y, Miao Z, Wang J, Chen J, Lv Y, Xing D, Wang X, Wang Y, Cao Z, Zhao Z.

Tumori. 2019 Apr 4:300891619839475. doi: 10.1177/0300891619839475. [Epub ahead of print]

PMID:
30945608
14.

Surgical Management of Primary Bone Lymphoma of the Hip: A Case Report and Review of the Literature.

Kennedy G, Weir P, Johnston K, Elder P.

Case Rep Orthop. 2019 Mar 3;2019:3174768. doi: 10.1155/2019/3174768. eCollection 2019.

15.

Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303.

Bartlett NL, Wilson WH, Jung SH, Hsi ED, Maurer MJ, Pederson LD, Polley MC, Pitcher BN, Cheson BD, Kahl BS, Friedberg JW, Staudt LM, Wagner-Johnston ND, Blum KA, Abramson JS, Reddy NM, Winter JN, Chang JE, Gopal AK, Chadburn A, Mathew S, Fisher RI, Richards KL, Schöder H, Zelenetz AD, Leonard JP.

J Clin Oncol. 2019 Apr 2:JCO1801994. doi: 10.1200/JCO.18.01994. [Epub ahead of print]

PMID:
30939090
16.

Polatuzumab vedotin or pinatuzumab vedotin plus rituximab in patients with relapsed or refractory non-Hodgkin lymphoma: final results from a phase 2 randomised study (ROMULUS).

Morschhauser F, Flinn IW, Advani R, Sehn LH, Diefenbach C, Kolibaba K, Press OW, Salles G, Tilly H, Chen AI, Assouline S, Cheson BD, Dreyling M, Hagenbeek A, Zinzani PL, Jones S, Cheng J, Lu D, Penuel E, Hirata J, Wenger M, Chu YW, Sharman J.

Lancet Haematol. 2019 Mar 29. pii: S2352-3026(19)30026-2. doi: 10.1016/S2352-3026(19)30026-2. [Epub ahead of print]

PMID:
30935953
17.

Correlations between MDCT features and clinicopathological findings of primary adrenal lymphoma.

Yang L, Zhang M, Zhao S, Hu Y, Yao J.

Eur J Radiol. 2019 Apr;113:110-115. doi: 10.1016/j.ejrad.2019.02.003. Epub 2019 Feb 2.

PMID:
30927934
18.

Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients.

Schorb E, Finke J, Ihorst G, Kasenda B, Fricker H, Illerhaus G.

BMC Cancer. 2019 Mar 29;19(1):287. doi: 10.1186/s12885-019-5473-z.

19.

Central Nervous System Involvement of Natural Killer and T Cell Neoplasms.

Aaroe AE, Nevel KS.

Curr Oncol Rep. 2019 Mar 27;21(5):40. doi: 10.1007/s11912-019-0794-2. Review.

PMID:
30919085
20.

The Impact of Surgery on Long-Term Survival of Patients with Primary Gastric Diffuse Large B-Cell Lymphoma: A SEER Population-Based Study.

Lin JL, Lin JX, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Zheng CH, Huang CM.

Gastroenterol Res Pract. 2019 Feb 24;2019:9683298. doi: 10.1155/2019/9683298. eCollection 2019.

Supplemental Content

Loading ...
Support Center